Category: PROFILES

This section profiles Cancer Consortium members.

Soligenix (SNGX)

  Mature pipeline of biopharmaceuticals for rare diseases. Government funding for biodefense business. Overview Soligenix¬†is a two-segment business. They have a biotherapeutics rare disease segment focused on cancer, cancer supportive care and […]


A new diagnostic technology can predict how patients will respond different drugs or drug combinations before the patients take the drugs. Overview Travera is using a breakthrough technology to measure which cancer […]

The Cancer Consortium